title: Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis.
abstract: Zoledronic acid, a bisphosphonate, has been approved for treatment and prevention of osteoporosis. This case describes a 73-year-old woman with primary osteoporosis who developed transient hepatotoxicity after zoledronic acid (ZOL) treatment. Three days after ZOL infusion, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltransferase (GGT) were increased by 9.9, 8.1, and 3.7 times, respectively, compared with pretreatment values. Liver protective agents were administered. The aminotransferase returned within normal ranges 12 days post-infusion. Currently, the relationship of ZOL and liver damage is not quite clear, which cannot be explained by its pharmacokinetics. The aim of this case report is to increase the clinician's awareness of the possible adverse effect on the liver, and ZOL should be cautiously administered in patients with liver disease.
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Yanhui
authors.initials: Y
authors.lastname: Lu
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: Pei
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Yinghong
authors.initials: Y
authors.lastname: Shao
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Shuangtong
authors.initials: S
authors.lastname: Yan
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Lichao
authors.initials: L
authors.lastname: Ma
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Fusheng
authors.initials: F
authors.lastname: Fang
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Mengmeng
authors.initials: M
authors.lastname: Jin
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Minyan
authors.initials: M
authors.lastname: Liu
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.affiliation: Department of Geriatric Endocrinology, Chinese PLA General Hospital, No. 28 Fuxing Road, 100853 Beijing, China.
authors.forename: Chunlin
authors.initials: C
authors.lastname: Li
keywords: bisphosphonates; hepatotoxicity; osteoporosis